121 related articles for article (PubMed ID: 8151329)
1. Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer.
Bennett JM; Troxel AB; Gelman R; Falkson G; Coccia-Portugal MD; Dreicer R; Tormey DC; Rushing D
J Clin Oncol; 1994 Apr; 12(4):874-5. PubMed ID: 8151329
[No Abstract] [Full Text] [Related]
2. Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer.
Falkson G; Gelman RS; Dreicer R; Tormey DC; Alberts AS; Coccia-Portugal MA; Rushing D; Bennett JM
J Clin Oncol; 1989 Sep; 7(9):1252-9. PubMed ID: 2671284
[TBL] [Abstract][Full Text] [Related]
3. Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Ruggeri EM; Alimonti A; Nardoni C; Cognetti F
Ann Oncol; 2005 Jul; 16(7):1209-10. PubMed ID: 15857847
[No Abstract] [Full Text] [Related]
4. Bone marrow stem cell disorders and mitolactol.
J Clin Oncol; 1990 Apr; 8(4):751-3. PubMed ID: 2313338
[No Abstract] [Full Text] [Related]
5. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
Saso R; Kulkarni S; Mitchell P; Treleaven J; Swansbury GJ; Mehta J; Powles R; Ashley S; Kuan A; Powles T
Br J Cancer; 2000 Jul; 83(1):91-4. PubMed ID: 10883674
[TBL] [Abstract][Full Text] [Related]
6. Long-term complications of cancer chemotherapy.
Pedersen-Bjergaard J
J Clin Oncol; 1995 Jul; 13(7):1534-6. PubMed ID: 7602341
[No Abstract] [Full Text] [Related]
7. Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.
Barnard DR; Woods WG
Leuk Lymphoma; 2005 May; 46(5):651-63. PubMed ID: 16019502
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal translocations in secondary acute myeloid leukemia.
Rowley JD; Vignon C; Gollin SM; Rosenberg CL; Wyandt HE; Milunsky A
N Engl J Med; 1996 Feb; 334(9):601-3. PubMed ID: 8569841
[No Abstract] [Full Text] [Related]
9. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
10. [Therapy-related acute leukaemia and myelodysplastic syndrome].
Díaz Beveridge R; Aparicio Urtasun J
An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
12. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
14. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
15. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.
Tallman MS; Gray R; Bennett JM; Variakojis D; Robert N; Wood WC; Rowe JM; Wiernik PH
J Clin Oncol; 1995 Jul; 13(7):1557-63. PubMed ID: 7602344
[TBL] [Abstract][Full Text] [Related]
16. Secondary leukaemia after MMM combined modality therapy for breast carcinoma.
Philpott NJ; Bevan DH; Gordon-Smith EC
Lancet; 1993 May; 341(8855):1289. PubMed ID: 8098437
[No Abstract] [Full Text] [Related]
17. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
Yagita M; Ieki Y; Onishi R; Huang CL; Adachi M; Horiike S; Konaka Y; Taki T; Miyake M
Int J Oncol; 1998 Jul; 13(1):91-6. PubMed ID: 9625808
[TBL] [Abstract][Full Text] [Related]
18. AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in treatment-induced leukemia after breast cancer.
La Starza R; Sambani C; Crescenzi B; Matteucci C; Martelli MF; Mecucci C
Haematologica; 2001 Feb; 86(2):212-3. PubMed ID: 11224496
[No Abstract] [Full Text] [Related]
19. Myelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with 2-deoxycoformycin.
Todd SA; Morris TC; Alexander HD
Leuk Lymphoma; 2002 Jun; 43(6):1343-4. PubMed ID: 12153007
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor and severe aplastic anemia.
Alter BP; Rosenberg PS
Blood; 2007 May; 109(10):4589; author reply 4589-90. PubMed ID: 17483301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
